国民视光 EYE
$17.90 +$0.05 (+0.28%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $17.90 0.00%
开盘$17.46
昨收$17.85
当日区间$17.23 – $18.19
成交量1.63M
市值$1.42B
市盈率（TTM）28.9
股息率–
EYE 相关新闻
匹配 National Vision 或代码 EYE 的头条新闻，按最新排序。
- Needs Well: Neezwell strengthens its IT infrastructure modernization services with an eye toward the AI era.
- China Merchants Securities International: Humanoid robots enter mass delivery phase; supply chain shifts toward platformization and modularity. Keep an eye on Ubtech Robotics (09880) and others.
- Aier Eye Hospital (300015): Back tax payments impact short-term profits; H-share listing preparations strengthen internationalization. 正面
- ANI Pharmaceuticals To Present Data From SYNCHRONICITY Phase 4 Clinical Trial Of Fluocinolone Acetonide Intravitreal Implant In Patients With Chronic Non-Infectious Uveitis Affecting The Posterior Segment Of The Eye In Oral Presentation During Uveitis...
- On September 30, Chaoju Eye Care (02219) repurchased 36,500 shares for HK$88,200.
- Shanghai Harbor (605598): Short-term profit margins under pressure; keep an eye on developments in the commercial space sector. 正面
- Needs Well: Promoting the development of data‑driven talent with an eye toward the AI era.
- Aier Eye Hospital: Legal Opinion of Hunan Qiyuan Law Firm Regarding the First Extraordinary Shareholders' Meeting of Aier Eye Hospital Group Co., Ltd. for 2026
- Xingqi Eye Medicine: Legal Opinion of King & Wood Mallesons Beijing on the Second Extraordinary Shareholders' Meeting of Shenyang Xingqi Eye Medicine Co., Ltd. for 2026
- Guggenheim Maintains National Vision(EYE.US) With Buy Rating, Cuts Target Price to $27 负面
- Barclays Maintains National Vision(EYE.US) With Buy Rating, Maintains Target Price $27
- Cat Eye Entertainment (01896.HK): Film business under short-term pressure; summer box-office season showing signs of recovery; IP business expanding steadily.
- TopCloudAg (301556): Project timelines are weighing on near-term revenue; keep an eye on opportunities arising from business model evolution.
- Aier Eye Hospital (300015): Earnings in the first half of 2026 are expected to be volatile, with the refractive surgery business posting rapid growth. 正面
- Aier Eye Hospital (300015): Revenue in 26H1 grew steadily, with outpatient visits and surgical procedures continuing to rise. 正面
暂无评论——快来第一个聊聊 EYE。
登录后参与讨论。